BUSINESS● LOWAug 13 · Aug 13, 2026, 11:03 AM
VYNE Therapeutics GAAP EPS of -$2.14 misses by $1.92
Seeking Alpha Tech
VYNE Therapeutics reported its GAAP earnings per share, which were -$2.14. This figure missed expectations by $1.92.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS17m agoN4,000/$ Exchange Rate: NDC asks why refineries are not workingVanguard NigeriaBUSINESS22m agoAt 50: Brand refresh raises questions about heritage, consumer loyaltyVanguard Nigeria